Calzada Limited

Calzada Limited is a biotechnology company with two wholly owned subsidiaries (PolyNovo Biomaterials and Metabolic Pharmaceuticals), both with high potential and maturing products reaching major value inflexion points during 2012 & 2013.


Calzada is listed on the Australian Securities Exchange (Code CZD).

Our Markets

PolyNovo has developed a unique biodegradable polymer platform technology (NovoSorb™) designed to be used in medical devices and for tissue engineering scaffolds. 


Metabolic is seeking to derive value from the Company’s past investment of over $50 million in the pharmaceutical development of AOD9604.